A. E. UZASLAN Et Al. , "How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?," American Thoracic Society Congress 2017 , vol.195, Washington, Kiribati, pp.1701, 2017
UZASLAN, A. E. Et Al. 2017. How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?. American Thoracic Society Congress 2017 , (Washington, Kiribati), 1701.
UZASLAN, A. E., ACET ÖZTÜRK, N. A., GÖREK DİLEKTAŞLI, A., DEMİRDÖĞEN ÇETİNOĞLU, E., COŞKUN, N. F., URSAVAŞ, A., ... KARADAĞ, M.(2017). How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations? . American Thoracic Society Congress 2017 (pp.1701). Washington, Kiribati
UZASLAN, AYŞE Et Al. "How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?," American Thoracic Society Congress 2017, Washington, Kiribati, 2017
UZASLAN, AYŞE E. Et Al. "How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?." American Thoracic Society Congress 2017 , Washington, Kiribati, pp.1701, 2017
UZASLAN, A. E. Et Al. (2017) . "How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?." American Thoracic Society Congress 2017 , Washington, Kiribati, p.1701.
@conferencepaper{conferencepaper, author={AYŞE ESRA UZASLAN Et Al. }, title={How Different Is Medication Adherence in Severe COPD Population with High Risk for Exacerbations?}, congress name={American Thoracic Society Congress 2017}, city={Washington}, country={Kiribati}, year={2017}, pages={1701} }